Actively Recruiting
Dexmedetomidine as an Adjuvant During Dural Puncture Epidural
Led by Menoufia University · Updated on 2026-04-01
140
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for epidural labor analgesia, and to assess the benefits of the dural puncture epidural.
CONDITIONS
Official Title
Dexmedetomidine as an Adjuvant During Dural Puncture Epidural
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women in labor attending Emergency Department with cervical dilation of 3-5 cm
- Normally positioned single fetus with intact fetal membranes
- Free from exclusion criteria
You will not qualify if you...
- Abnormal fetal presentation or lie
- Premature rupture of membranes
- Maternal fever
- Fetal distress
- Pregnancy-induced diseases
- Abnormal placental position
- ASA grade higher than II
- Marked obesity
- Allergy or contraindications to study drugs
- Spinal deformity or disorders
- Skin diseases or infection at injection site
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Faculty of Medicine Menoufia University
Shebeen El Kom, Egypt, 32511
Actively Recruiting
Research Team
R
Rabab Habeeb, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here